Cirrhosis is a chronic liver disease affecting millions of people worldwide. Its prevalence increases with age and is often complicated by neurocognitive dysfunction. Our research team has explored how aging exacerbates the connection between the liver and the brain in cirrhosis. Our findings, published in Aging and Disease, shed light on the mechanisms driving these effects.
Key Findings:
- Greater liver damage in aged mice:
We observed significantly increased liver fibrosis in older mice, evidenced by higher expression of genes linked to scarring (e.g., Timp1 and Acta2) and markers such as collagen and alpha-SMA. - Worse cognitive and motor function:
Aged cirrhotic mice showed pronounced deficits in neuromotor performance and memory tasks, such as object recognition tests, compared to their younger counterparts. - Weakened barriers between the liver and brain:
We found impaired blood-brain barrier (BBB) integrity in aged cirrhotic mice, accompanied by astrocyte activation and increased apoptosis markers. This highlights how aging exacerbates the brain’s vulnerability to cirrhosis-related damage. - Expansion of adaptive T cell subpopulations:
Cirrhosis in aged mice led to an increased presence of CD8+ T cells in the liver and brain, alongside a pro-inflammatory Th17 profile in CD4+ T cells. Interestingly, this T cell expansion did not enhance cytolytic activity. Instead, levels of perforin, a protein crucial for eliminating harmful cells, were reduced. - Elevated ammonia levels:
Aged cirrhotic mice exhibited significantly higher ammonia levels in their liver, brain, and bloodstream. This ammonia buildup directly correlated with neuromotor and cognitive deficits.
Why This Study Matters
Our work demonstrates that aging not only worsens liver damage in cirrhosis but also exacerbates brain dysfunction through a complex interplay of inflammation, ammonia toxicity, and blood-brain barrier disruption. These findings underscore the urgent need to develop targeted therapies for older patients with cirrhosis, considering the age-related impact on the liver-brain axis.
We remain committed to advancing research in this field to better understand and treat cirrhosis. If you’d like to learn more about our work or collaborate with us, don’t hesitate to reach out!
